Compare BGC & BLLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BGC | BLLN |
|---|---|---|
| Founded | 1945 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Bankers/Brokers/Service | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.4B | 3.9B |
| IPO Year | 1999 | 2025 |
| Metric | BGC | BLLN |
|---|---|---|
| Price | $9.03 | $87.17 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 6 |
| Target Price | $14.50 | ★ $137.83 |
| AVG Volume (30 Days) | ★ 2.0M | 259.9K |
| Earning Date | 02-12-2026 | 12-09-2025 |
| Dividend Yield | ★ 0.88% | N/A |
| EPS Growth | ★ 36.46 | N/A |
| EPS | ★ 0.33 | N/A |
| Revenue | ★ $2,640,884,000.00 | $254,136,000.00 |
| Revenue This Year | $36.34 | $98.01 |
| Revenue Next Year | $11.45 | $35.84 |
| P/E Ratio | $27.38 | ★ N/A |
| Revenue Growth | 24.59 | ★ 254.30 |
| 52 Week Low | $7.24 | $80.51 |
| 52 Week High | $10.96 | $138.70 |
| Indicator | BGC | BLLN |
|---|---|---|
| Relative Strength Index (RSI) | 54.68 | N/A |
| Support Level | $8.59 | N/A |
| Resistance Level | $8.89 | N/A |
| Average True Range (ATR) | 0.20 | 0.00 |
| MACD | -0.00 | 0.00 |
| Stochastic Oscillator | 66.67 | 0.00 |
BGC Group Inc is a brokerage and financial technology company that serves financial markets, energy, and commodities markets. Its service and product offerings include brokerage for a wide range of financial products, including fixed income, equities, commodities, derivatives, and real estate, software solutions for trading platforms, clearing, trade execution, and other back-office services. Its clients mostly include banks, financial institutions, and corporate clients. BGC operates in one reportable segment, which is providing brokerage services. Geographically, the company generates a majority of its revenue from Europe, Middle East and Africa (EMEA), followed by the Americas and the Asia-Pacific region.
BillionToOne Inc is a precision diagnostics company revolutionizing molecular testing with its patented Quantitative Counting Templates (QCT) platform. This technology enables ultrasensitive, single-molecule DNA quantification, making genetic testing more accurate, affordable, and accessible. The company serves prenatal screening and oncology markets with non-invasive tests that detect fetal genetic risks and monitor cancer therapy response.